ライフサイエンスコーパス: sexually transmitted disease

1 ogenital tract infection by Chlamydia causes sexually transmitted disease.

2 trachomatis, the leading cause of bacterial sexually transmitted disease.

3 n of increased risk was found for history of sexually transmitted disease.

4 nts attending United States clinics treating sexually transmitted disease.

5 medical service utilization, disability, and sexually transmitted disease.

6 s, and it can have social ramifications as a sexually transmitted disease.

7 -negative bacterium that causes chancroid, a sexually transmitted disease.

8 and African-American women at high risk for sexually transmitted disease.

9 e etiological agent of blinding trachoma and sexually transmitted disease.

10 is is a pathogen responsible for a prevalent sexually transmitted disease.

11 n-] strains, probably reflecting its being a sexually transmitted disease.

12 uals globally, causing blinding trachoma and sexually transmitted disease.

13 s trichomonosis, the most prevalent nonviral sexually transmitted disease.

14 scuss global initiatives for surveillance of sexually transmitted diseases.

15 typing of C. trachomatis strains that cause sexually transmitted diseases.

16 ymptomatic BV who were also at high risk for sexually transmitted diseases.

17 ndidiasis has a much weaker association with sexually transmitted diseases.

18 ould play an important role in the spread of sexually transmitted diseases.

19 gynecologic complications and acquisition of sexually transmitted diseases.

20 s deficiency could predispose individuals to sexually transmitted diseases.

21 y and physiology, and a higher prevalence of sexually transmitted diseases.

22 ium responsible for ocular, respiratory, and sexually transmitted diseases.

23 ection is the most common cause of bacterial sexually transmitted diseases.

24 bacterial vaginosis (BV) and acquisition of sexually transmitted diseases.

25 herpes simplex is one of the most prevalent sexually transmitted diseases.

26 uggest their importance in immunity to other sexually transmitted diseases.

27 way a core population does in the setting of sexually transmitted diseases.

28 nts are needed to protect men and women from sexually transmitted diseases.

29 analysis was controlled for the presence of sexually transmitted diseases.

30 f the genital mucosae are a leading cause of sexually transmitted diseases.

31 ause of preventable blindness worldwide, and sexually transmitted diseases.

32 but no effect was seen among men with other sexually transmitted diseases.

33 ne effectors is the goal of vaccines against sexually transmitted diseases.

34 s, including a prominent role for coincident sexually transmitted diseases.

35 event human immunodeficiency virus and other sexually transmitted diseases.

36 oxic agents are needed to protect women from sexually transmitted diseases.

37 rol group received standard counseling about sexually transmitted diseases.

38 trol and Prevention treatment guidelines for sexually transmitted diseases.

39 ss could be made towards improved control of sexually transmitted diseases.

40 ting cocaine, imprisonment, and a history of sexually transmitted diseases.

41 the age group at greatest risk for acquiring sexually transmitted diseases.

42 esting for other causes of liver disease and sexually transmitted diseases.

43 c plague, secondary hospital infections, and sexually transmitted diseases.

44 y to address the current epidemic problem of sexually transmitted diseases.

45 ally transmitted pathogens, particularly for sexually transmitted diseases.

46 vulnerability to predation, and exposure to sexually transmitted diseases.

47 une surveillance and in host defense against sexually transmitted diseases.

48 the exact role local IgG plays in preventing sexually transmitted diseases.

49 in clinics for the treatment of persons with sexually transmitted diseases.

50 rial pathogen linked to urethritis and other sexually transmitted diseases.

51 th problems, including blinding trachoma and sexually transmitted diseases.

52 with multiple partners or those at risk for sexually transmitted diseases (0.4% to 1.8% per year).

53 prevention (2.4%), mental health (4.1%), or sexually transmitted diseases (2.7%).

54 mmunodeficiency virus (HIV) type 1 and other sexually transmitted diseases, a prospective cohort stud

55 nse to treatment, relapse rate, and risk for sexually-transmitted-disease acquisition among women wit

56 ociated with reported lifetime experience of sexually transmitted diseases (adjusted OR 3.69 [95% CI

57 KSHV is a sexually transmitted disease among homosexual men, but o

58 the bacterium that causes gonorrhea, a major sexually transmitted disease and a significant cofactor

59 bal health burden due to its prevalence as a sexually transmitted disease and as the causative agent

60 chomatis reference serotypes responsible for sexually transmitted disease and blinding trachoma synth

61 acterial pathogen that is a leading cause of sexually transmitted disease and blinding trachoma.

62 ovariants are the leading cause of bacterial sexually transmitted disease and infectious preventable

63 amydia trachomatis (Ctr) is a major cause of sexually transmitted disease and infertility worldwide.

64 Herpes infections are among the most common sexually transmitted diseases and are the most common ca

65 eographic areas with high prevalence of HIV, sexually transmitted diseases and genital cancers.

66 seropositivity correlated with a history of sexually transmitted diseases and had a linear associati

67 reased risk for bloodborne viral infections, sexually transmitted diseases, and mental health symptom

68 ness for acquired immunodeficiency syndrome, sexually transmitted diseases, and tuberculosis as a gro

69 Sexually transmitted diseases are increasing rapidly in

70 porting a history of influenza/pneumonia and sexually transmitted disease around the time of pregnanc

71 rial pathogen linked to urethritis and other sexually transmitted diseases as well as respiratory and

72 Trichomoniasis is a common sexually transmitted disease associated with preterm bir

73 ce and safer sex practices for prevention of sexually transmitted disease but also providing opportun

74 obiotypes associated with either trachoma or sexually transmitted diseases, but differences within th

75 cal microbicides are being sought to prevent sexually transmitted diseases by inactivating pathogens

76 elopment of a protective vaccine against the sexually transmitted disease caused by Chlamydia trachom

77 Chancroid, a sexually transmitted disease caused by Haemophilus ducre

78 Gonorrhea, a sexually transmitted disease caused by Neisseria gonorrh

79 Syphilis is a complex sexually transmitted disease caused by the spirochetal b

80 tial components of a subunit vaccine against sexually transmitted diseases caused by C. trachomatis.

81 Haemophilus ducreyi causes the sexually transmitted disease chancroid and a chronic lim

82 Haemophilus ducreyi causes the sexually transmitted disease chancroid in adults and cut

83 Haemophilus ducreyi, the cause of the sexually transmitted disease chancroid produces a lipool

84 mophilus ducreyi, the etiologic agent of the sexually transmitted disease chancroid, has been shown t

85 Haemophilus ducreyi causes the sexually transmitted disease chancroid, which facilitate

86 uman pathogen and the causative agent of the sexually transmitted disease chancroid.

87 llidum is the causative agent of syphilis, a sexually transmitted disease characterized by widespread

88 were collected from individuals attending a sexually transmitted disease clinic and three HIV clinic

89 n to occur in immunocompromised individuals, sexually transmitted disease clinic attendees, and child

90 ded the San Francisco, California, municipal sexually transmitted disease clinic between 1989 and 199

91 m 3 consecutive groups of 10 men attending a sexually transmitted disease clinic by use of (1) a sali

92 rleans, Louisiana, public family planning or sexually transmitted disease clinic from July 1995 to Ju

93 fied among men presenting for screening at a sexually transmitted disease clinic in Columbus, Ohio, w

94 f genital ulcers in patients presenting to a sexually transmitted disease clinic in Dakar, Senegal, a

95 tion, using patient data from a metropolitan sexually transmitted disease clinic in Denver, Colorado

96 atients repeatedly tested for the virus at a sexually transmitted disease clinic in New Orleans, Loui

97 -month period in 1992-1994, all clients of a sexually transmitted disease clinic in rural North Carol

98 genitalium infection in patients attending a sexually transmitted disease clinic in San Antonio, TX,

99 ecton Dickinson Co.) in MSM seen at the city sexually transmitted disease clinic in San Francisco, CA

100 imens from women recruited in the Harborview Sexually Transmitted Disease Clinic in Seattle from 1984

101 At a sexually transmitted disease clinic in Seattle, Washingt

102 pharyngeal gonorrhea during 1993-2011, at a sexually transmitted disease clinic in Seattle, Washingt

103 surveillance was conducted in a Minneapolis sexually transmitted disease clinic on 28 newly diagnose

104 m a prospective cohort study of 1,122 female sexually transmitted disease clinic patients in Alabama

105 STARHS was offered to sexually transmitted disease clinic patients to estimate

106 ary 1988 and January 1993 at a New York City sexually transmitted disease clinic serving predominantl

107 -label, noncomparative trial in 5 outpatient sexually transmitted disease clinic sites in Alabama, Ca

108 the ages of 16 and 50 years presenting to a sexually transmitted disease clinic with urogenital gono

109 mptomatic males at San Francisco's municipal sexually transmitted disease clinic, a participant in th

110 on of infection in women and men attending a sexually transmitted disease clinic.

111 ipants were men aged 18-70 years attending a sexually transmitted disease clinic.

112 al specimens obtained from women attending a sexually transmitted disease clinic.

113 Data were collected in an urban sexually transmitted diseases clinic from patients who h

114 lish-speaking males >/=16 years, attending a sexually transmitted diseases clinic in Seattle, Washing

115 A cross-sectional study was conducted in a sexually transmitted diseases clinic to determine the pr

116 Consecutive men attending a sexually transmitted diseases clinic were enrolled in a

117 Men attending a sexually transmitted diseases clinic were tested for tri

118 human immunodeficiency virus clinics and one sexually transmitted diseases clinic) located in Birming

119 se was assessed in 1179 patients attending a sexually transmitted diseases clinic.

120 ) in heterosexual men presenting to an urban sexually transmitted diseases clinic.

121 n C. trachomatis-infected subjects seen at a sexually transmitted diseases clinic.

122 highest rate was found in patients tested at sexually transmitted disease clinics (43%).

123 re for patients attending two Baltimore City sexually transmitted disease clinics and a clinic for ad

124 entions conducted at five publicly funded US sexually transmitted disease clinics between 1993 and 19

125 inal swab specimens from 936 women attending sexually transmitted disease clinics in Seattle, Wash. (

126 eillance Project (GISP) from sentinel public sexually transmitted disease clinics in the USA, includi

127 Samples from patients attending sexually transmitted disease clinics were collected in d

128 More than 3,000 women attending two sexually transmitted disease clinics were enrolled in th

129 23 acute HIV infections, 16 were detected at sexually transmitted disease clinics.

130 d 18 to 40 attending primary health care and sexually transmitted disease clinics.

131 m high-risk female populations attending two sexually transmitted disease clinics.

132 orrhoeae are common among patients attending sexually transmitted disease clinics.

133 22 centers, enrolled 1862 persons attending sexually transmitted disease clinics.

134 testinal, and gynaecological signs including sexually-transmitted diseases, depression, and post-trau

135 Health consequences of sexually transmitted diseases disproportionately affect

136 d women, with or without symptoms, attending sexually transmitted disease, family planning, and obste

137 ing the female reproductive tract, including sexually transmitted diseases, fungal and bacterial infe

138 eria gonorrhoeae, the causative agent of the sexually transmitted disease gonorrhea, can be studied u

139 bacterial meningitis and septicemia, and the sexually transmitted disease gonorrhea, respectively.

140 N. gonorrhoeae, the etiological agent of the sexually transmitted disease gonorrhea.

141 he gonococcus) is the causative agent of the sexually transmitted disease gonorrhoea.

142 smitted diseases, but differences within the sexually transmitted disease group have not yielded reli

143 Classic modeling of sexually transmitted diseases has focused on modeling be

144 Examples include limited sexually transmitted disease, HIV and pregnancy testing;

145 dividuals exposed to a mild and long-lasting sexually transmitted disease, i.e. without disease-induc

146 cause genital warts, and are the most common sexually transmitted disease in many countries.

147 dia trachomatis is the most common bacterial sexually transmitted disease in the United States and a

148 omatis is the most common cause of bacterial sexually transmitted disease in the United States and th

149 omatis is the most common cause of bacterial sexually transmitted disease in the United States and th

150 omatis is the most common cause of bacterial sexually transmitted disease in the United States, as we

151 The infection is also a leading cause of sexually transmitted disease in the United States.

152 hlamydia trachomatis is the leading cause of sexually transmitted disease in the United States.

153 tis infections are the most common bacterial sexually transmitted disease in the United States.

154 matis infection is the most common bacterial sexually transmitted disease in the United States.

155 matis infection is the most common bacterial sexually transmitted disease in the United States.

156 ntly no other animal model available for any sexually transmitted disease in which the disease or the

157 an immunodeficiency virus type 1 (HIV-1) and sexually transmitted diseases in a population of sex wor

158 We enrolled women with nonviral sexually transmitted diseases in a randomized trial of a

159 n appears to reduce the infection of several sexually transmitted diseases in randomized control tria

160 IUDs affect long-term fertility or increase sexually transmitted diseases in teens.

161 on in Trinidad, 83 samples from a clinic for sexually transmitted diseases in the Bahamas, 10 confirm

162 tion in women with anogenital warts or other sexually transmitted diseases, in their sex partners, an

163 ays have been performed for the detection of sexually transmitted diseases, including Chlamydia trach

164 mcision provides substantial protection from sexually transmitted diseases, including HIV-1, and the

165 ucts topically applied for the prevention of sexually transmitted diseases, including HIV-1.

166 condition associated with increased risk of sexually transmitted diseases, including human immunodef

167 provides protection from the acquisition of sexually transmitted diseases, including human immunodef

168 ute of transmission for most respiratory and sexually transmitted diseases, including human immunodef

169 nic women are disproportionately affected by sexually transmitted diseases, including the acquired im

170 esting; given the high rates of asymptomatic sexually transmitted disease infection, universal screen

171 cal agent of blinding trachoma and bacterial sexually transmitted diseases, infections that afflict h

172 Sexually transmitted disease intervention programs based

173 Development of structured sexually transmitted disease intervention programs utili

174 mating partners, indicating that the risk of sexually transmitted disease is likely to be a major fac

175 genitalium, a human pathogen associated with sexually transmitted diseases, is capable of causing chr

176 the leading bacterial agent responsible for sexually transmitted diseases, is required to invade gen

177 genitalium, a human pathogen associated with sexually transmitted diseases, is unique in that it has

178 al gene transfer (LGT) have been detected in sexually transmitted disease isolates of Chlamydia trach

179 gen systems, particularly macroparasites and sexually transmitted diseases, it has been found that ap

180 Because dogs are particularly resilient to sexually transmitted diseases, it has been proposed that

181 y pathogen, causing bovine trichomoniasis, a sexually transmitted disease leading to infertility and

182 omatis infection is the most common cause of sexually transmitted disease, leading to female pelvic i

183 is, the causative agent of trachoma and many sexually transmitted diseases , leads to the accumulatio

184 atitis include benign prostatic hyperplasia, sexually transmitted disease, lower urinary tract sympto

185 t for human trichomoniasis, is a problematic sexually transmitted disease mainly in women, where it m

186 produced during opportunistic infections or sexually transmitted diseases, may predispose macrophage

187 Women at low risk of sexually transmitted diseases (n = 210) were recruited i

188 1986 and 1998-2000 were having a history of sexually transmitted disease, number of sex partners, an

189 intracellular bacterial pathogens that cause sexually transmitted diseases, ocular infections and aty

190 n the clinical manifestations of syphilis, a sexually transmitted disease of humans caused by spiroch

191 oncepts borrowed from the study of venereal (sexually transmitted) diseases of animals do not adequat

192 nal swabs were obtained from women attending sexually transmitted disease or family planning clinics

193 The most common features were a history of sexually transmitted disease or pelvic inflammatory dise

194 Inflammation did not correlate with sexually transmitted diseases or HIV disease stage.

195 = 3.3; 95% CI: 1.7, 6.2), and history of any sexually transmitted disease (OR = 2.0; 95% CI: 1.1, 3.5

196 ose unflattering (drug use, poor grades, and sexually transmitted diseases) or flattering (blood dona

197 ated activation of gene transcription in the sexually transmitted disease pathogen Neisseria gonorrho

198 tudies have reported that infection with the sexually transmitted disease pathogen Neisseria gonorrho

199 n promise in development of immunity against sexually transmitted disease pathogens, in part due to t

200 Frequently seen medical conditions including sexually transmitted diseases, pregnancy, and psychiatri

201 STC-1 included exposure to sexually transmitted diseases, presumptive CT treatment

202 School-based sexually transmitted disease programs can reach the majo

203 M. genitalium infection in women attending a sexually transmitted disease-related health clinic in Sa

204 he genitourinary tracts of women attending a sexually transmitted disease-related health clinic, plus

205 the provision of contraceptive services and sexually transmitted disease screening from requirements

206 so than interventions such as improvement of sexually transmitted disease services and universal prov

207 Interviews focused on history of sexually transmitted diseases, sexual behavior, and ciga

208 ing trachoma, the leading cause of bacterial sexually transmitted diseases, significant respiratory p

209 Biomedical innovations for sexually transmitted disease (STD) and HIV prevention ha

210 Men attending a sexually transmitted disease (STD) clinic for a new comp

211 cohorts of subjects who had visited either a sexually transmitted disease (STD) clinic for genital tr

212 Case patients were men who attended a sexually transmitted disease (STD) clinic in Seattle, Wa

213 high prevalences have been identified among sexually transmitted disease (STD) clinic patients and i

214 was determined among 1766 patients attending sexually transmitted disease (STD) clinics and enrolled

215 We examined attendance at sexually transmitted disease (STD) clinics and the preva

216 en who underwent HIV testing while attending sexually transmitted disease (STD) clinics in Baltimore,

217 roject AWARE randomized 5012 patients from 9 sexually transmitted disease (STD) clinics in the United

218 planning, obstetrics/gynecology (OB/GYN), or sexually transmitted disease (STD) clinics in the United

219 ed with rectal CT and/or GC in New York City sexually transmitted disease (STD) clinics was compared

220 fection was studied among 4128 patients from sexually transmitted disease (STD) clinics who were enro

221 T testing and infections among MSM attending sexually transmitted disease (STD) clinics.

222 between depression and HIV risk behaviors or sexually transmitted disease (STD) diagnosis at an urban

223 Chlamydia trachomatis is a major cause of sexually transmitted disease (STD) for which a vaccine i

224 important cause of preventable blindness and sexually transmitted disease (STD) in humans.

225 provide the first quantitative evidence of a sexually transmitted disease (STD) in social insects, in

226 Trichomoniasis is a significant sexually transmitted disease (STD) in the spectrum of pu

227 s level (p = 0.02), caries score (p = 0.02), sexually transmitted disease (STD) infection experience

228 ll patients (55.5%) reported treatment for a sexually transmitted disease (STD) or incarceration in a

229 crobicides to protect against infection with sexually transmitted disease (STD) pathogens.

230 Condom use remains important for sexually transmitted disease (STD) prevention.

231 s reported to the New York City HIV/AIDS and Sexually Transmitted Disease (STD) surveillance registri

232 d wives, sexual activities outside marriage, sexually transmitted disease (STD) symptoms, contracepti

233 ed as a possible cause of several idiopathic sexually transmitted disease (STD) syndromes.

234 Two randomised controlled trials of sexually transmitted disease (STD) treatment for the pre

235 Chlamydia trachomatis is a major cause of sexually transmitted disease (STD) worldwide.

236 e hypothesis that community-level control of sexually transmitted disease (STD) would result in lower

237 United States receive cervical screening in sexually transmitted disease (STD), family planning, and

238 V seropositivity, marital status, history of sexually transmitted disease (STD), older age, and highe

239 ositive if their partners had a history of a sexually transmitted disease (STD); however, their HIV p

240 4997829 and AD with respect to self-reported sexually transmitted disease (STD; z=-2.809, p=4.97 x 10

241 to the Jefferson County Department of Health Sexually Transmitted Diseases (STD) Clinic and receiving

242 Despite the significance for sexually transmitted diseases (STD) control in East Asia

243 n increase in high-risk sexual behaviour and sexually transmitted diseases (STD) during the time peri

244 Screening women for sexually transmitted diseases (STD) in nonclinic setting

245 5 Centers for Disease Control and Prevention sexually transmitted diseases (STD) treatment guidelines

246 ers for Disease Control and Prevention (CDC) Sexually Transmitted Diseases (STD) Treatment Guidelines

247 uestions and data that were discussed at the Sexually Transmitted Diseases (STD) Treatment Guidelines

248 prevalence, incidence, and risk factors for sexually transmitted diseases (STDs) among female adoles

249 Women with sexually transmitted diseases (STDs) and bacterial vagin

250 Sexually transmitted diseases (STDs) are a major health

251 Sexually transmitted diseases (STDs) are cofactors for h

252 V-1 infection through improved management of sexually transmitted diseases (STDs) by primary-health-c

253 Sexually transmitted diseases (STDs) enhance human immun

254 human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs) has not been defini

255 For two decades, treatment guidelines for sexually transmitted diseases (STDs) have recommended em

256 Screening for sexually transmitted diseases (STDs) in a greater propor

257 viral load, and for symptoms or diagnoses of sexually transmitted diseases (STDs) in the HIV-1-infect

258 genital herpes is 1 of the 3 most prevalent sexually transmitted diseases (STDs) in the United State

259 e tested in the past year for all 3 examined sexually transmitted diseases (STDs) increased from 20%

260 The burden of sexually transmitted diseases (STDs) is high in American

261 The population prevalence of many sexually transmitted diseases (STDs) is low.

262 US surveillance of sexually transmitted diseases (STDs) is often delayed an

263 Sexually transmitted diseases (STDs) occur throughout th

264 echniques becomes more widely used for other sexually transmitted diseases (STDs) such as gonorrhea a

265 Transmission of sexually transmitted diseases (STDs) such as human immun

266 The rate of infection with any of the three sexually transmitted diseases (STDs) tested was 14.1%.

267 oup to assist in development of the 2015 CDC sexually transmitted diseases (STDs) treatment guideline

268 o evaluate methods of detecting clients with sexually transmitted diseases (STDs) who were acutely co

269 n with average semen HIV-1 loads and without sexually transmitted diseases (STDs) would be expected t

270 at three major infectious diseases--malaria, sexually transmitted diseases (STDs), and tuberculosis--

271 Among individuals at risk for sexually transmitted diseases (STDs), the median seropre

272 urbances of vaginal flora and acquisition of sexually transmitted diseases (STDs).

273 , urinary tract infections (UTIs), and other sexually transmitted diseases (STDs).

274 se who use these drugs raises concerns about sexually transmitted diseases (STDs).

275 is of urinary tract infection (UTI) and some sexually-transmitted diseases (STDs), such as gonorrhea.

276 te the risk of neonatal infection (excluding sexually transmitted diseases [STDs] or congenital infec

277 Conjunctivitis secondary to sexually transmitted diseases such as chlamydia and gono

278 cular infection that leads to blindness, and sexually transmitted diseases such as pelvic inflammator

279 Associated sexually transmitted diseases (such as HIV) and suicide

280 gn of vaccines and vaccine vectors for other sexually transmitted diseases, such as AIDS.

281 or screening tests for asymptomatic women in sexually transmitted disease surveillance programs.

282 up in all sociodemographic, behavioural, and sexually transmitted disease symptom subgroups.

283 als of choice because of the similarity of a sexually transmitted disease syndrome and sequelae in sw

284 ncreasingly appreciated as a common cause of sexually transmitted disease syndromes, including urethr

285 f condoms, and significantly higher rates of sexually transmitted diseases than their peers.

286 creyi is the etiologic agent of chancroid, a sexually transmitted disease that increases the rate of

287 Chlamydia is a prevalent sexually transmitted disease that infects more than 100

288 This is true for some sexually transmitted diseases that are more easily caugh

289 ropriately assess risk for HIV infection and sexually transmitted diseases; they must inquire about b

290 sing a dynamic transmission model of HIV and sexually transmitted disease transmission that was param

291 Disease Control and Prevention published the Sexually Transmitted Diseases Treatment Guidelines 2002.

292 5 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines on hu

293 At 3 clinics for treatment of sexually transmitted disease, we recruited 521 female pa

294 th (n = 3) and without (n = 11) histories of sexually transmitted disease were evaluated.

295 Those with a history of sexually transmitted diseases were more likely and those

296 arasite that causes trichomoniasis, a common sexually transmitted disease with worldwide impact.

297 nalis, which causes the most common nonviral sexually transmitted disease worldwide, is itself common

298 matis is considered the most common agent of sexually transmitted disease worldwide.

299 a trachomatis is a major cause of ocular and sexually transmitted diseases worldwide.

300 ubstance abuse, motor vehicle accidents, and sexually transmitted diseases, yet little is known about